Atlas Trials

Efficacy and Safety of Actovegin in Post-stroke Cognitive Impairment (PSCI)

Clinical trial NCT01582854 · COMPLETED

Trial details

NCT number
NCT01582854
Sponsor
Takeda
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Post-Stroke Cognitive Impairment (PSCI)
Start date
2012-06-01
Primary completion
2014-11-01
Enrollment
503

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.